Completed Clinical Trials

S9810: Gemcitabine Plus Cisplatin in Treating Patients With Malignant Mesothelioma of the Pleura That Cannot Be Removed by Surgery

By April 24, 2017 No Comments

Condition

Malignant Mesothelioma

Estimated Enrollment: 57

Age Group: 18 Years and older   (Adult, Senior)

Gender: All

Study Type: Interventional

Study Design Allocation: Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Treatment

Study ID Numbers: CDR0000066832|SWOG-S9810|U10CA032102

Study First Received: November 1, 1999

Last Updated: October 5, 2012

Estimated Primary Completion Date: June 2007

 

Primary Outcome Measures:

Estimate overall survival|qualitative and quantitative toxicities|confirmed and unconfirmed complete and partial response

Sponsors and Collaborators:

Southwest Oncology Group|National Cancer Institute (NCI)

Website Link: https://ClinicalTrials.gov/show/NCT00003723

Leave a Reply

Call Now ButtonCall Now